NetherlandsStand No: 10F20
Aspen is a global supplier of branded and generic pharmaceutical products as well as infant nutritional and consumer healthcare products in selected territories. In line with the Group's commercial, production and territorial strategies, Aspen has identified thrombosis, anaesthetics, high potency & cytotoxics and infant nutritionals as four therapeutic categories which will get the highest focus based on materiality and future potential.The group has an extensive global presence with more than 10,000 employees. Aspen has a strong presence in both emerging and developed countries with more than ???????60 established business operations in approximately 50 countries. The Group supplies medicines and products to more than 150 countries. Aspen Oss B.V., established in 1923, is a leading global supplier of Active Pharmaceutical Ingredients (APIs) to the global pharmaceutical industry. Aspen Oss specializes in the manufacture of highly complex APIs and is dedicated to the production of high quality APIs. Our customers benefit from...
GermanyStand No: 10H6
AXXO is a leading international supplier with a rich product portfolio covering a wide range of therapeutic categories including active pharmaceutical ingredients (API), intermediates, finished dosage forms as well as the latest development in the field of biotech production i. e. monoclonal antibodies (MAB). Our international operating company would be pleased to offer you our custom-made services from developing, manufacturing and marketing APIs, finished dosage forms or registration dossiers to full health concepts like machinery & equipment for your own manufacturing. We are present in the EU, in a huge number of the CIS countries and in various South American and Middle East markets. Our product portfolio embraces APIs as well as finished formulations. Our dynamic and highly-motivated team is investigating, developing, producing and distributing innovative pharmaceutical products. We are offering just-in-time delivery, customized product parameters as well as registration assistance. Our expertise consists in the development and registration of...
SwitzerlandStand No: 8B20
Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership. Bachem. Pioneering Partner for Peptides
SpainStand No: 14.0G40
BCN Peptides is focused on the GMP manufacture of synthetic peptides API's for pharmaceutical and veterinary application. We manufacture from R&D to commercial quantities of generic peptides and NCE's. Our state of the heart facility is fully GMP, US FDA and EMEA approved.
IndiaStand No: 12J22
Biological E Limited established in 1953, leading manufacturer of Human vaccines Tetanus, DT, DTP, Td HepatitisB, DTP-HepB-Hib Pentavalent, Hib, IPV, Japanese encephalitis, Measles and Rubella, Tetanus Antitoxin and Snake Antivenin. Attained WHO prequalification for Tetanus, DTPHepBHib, JE, DTP and Td. APIs – Noscapine Base and HCL (Alkaloids) and Heparin Sodium. Pipeline Injectables - Heparin Inj, LMWH Enoxaparin, Dalteparin, Fosaprepitant, Daptomycin, Risperidone and Paliperidone Palmitate.
IndiaStand No: 6D40
Biophore, an established pharmaceutical company is engaged in the development and manufacture of niche pharmaceutical products for generic industry.Within a decade since inception in 2007, Biophore has emerged as a trusted partner in generic industry across US, Europe and other regulated markets. Biophore's product range is diverse and balanced with NCE, Branded products and grandfather products. Biophore's portfolio spread across 30 therapeutic segments, is specialized in development and manufacture of pharmaceutical actives for Oncology medications, Contrast and Diagnostic media. For updated list of products, send an email to [email protected]
BrazilStand No: 14.1G71
Blau Farmacêutica is a Brazilian pharmaceutical company, leader in Latin America, present in Argentina, Chile, Colombia, Peru and Uruguay. The company is a pioneer in highly complex medicines, specialized in biotechnology, oncology, nephrology, hematology, infectious diseases and others. Celebrating 30 years, Blau Farmacêutica is pleased to show your strength, competence and technique experienced in developing more than 100 different products. Blau's portfolio includes products, which are available for a wide range of applications. The excellence of these products, are a proof of the company's devotion to customer satisfaction and the well-being of its consumers.
TaiwanStand No: 6G30
Chirogate is a leading US-FDA inspected Prostaglandin (PG) manufacturer and owns more than 6 dedicated & cGMP-compliant production lines for cutting-edged manufacturing of PGs. Several process patents filed and granted worldwide are to provide a commercially revolutionary synthetic approach and an exciting spectrum of advanced intermediates for synthesis of new PG entities. US DMFs filed for Unoprostone Isopropyl, Treprostinil, Latanoprost, Bimatoprost, and Travoprost with additional registration experiences in China, Japan, Canada, Australia, New Zealand and major EU countries. Products: Unoprostone Isopropyl, Treprostinil, Treprostinil Sodium & Dienthanolamine, Beraprost Sodium, Carboprost Tromethamine, Iloprost Tromethamine, Latanoprostene Bunod, Latanoprost, Bimatoprost, Travoprost, Misoprostol, Lubiprostone, Epoprostenol Sodium, Dinoprostone, Tafluprost, Alprostadil, Dinoprost (& Tromethamine), and (+)-Cloprostenol (&Sodium).
SwitzerlandStand No: 9C50
Crystal Hemp is a Swiss Company that operates in the hemp sector and aims to produce and develop hemp extracts for every possible use through extensive investments in R&D. The Company is focusing on selling products to pharmaceutical, cosmeceutical and nutraceutical firms which are currently experiencing an increase in term of sales worldwide and operates in two different business fields: medical applications and hemp for industrial uses. Our business model is based on national and international supply chain of hemp from several selected farmers and international agreements for the extraction in a high-capacity plant (GMP certified facility) in order to offer the best products to the market. We will participate to the CPhI with our business partner Linnea SA.
ItalyStand No: 12J10
ESSETI FARMACEUTICI is an Italian pharmaceutical company that from its beginning in 1956 has invested in the internationalization process anticipating times on competition, tracing new paths in the export of Italian production, a best banner in the world capable of transmitting and ensuring high quality standards and competitive prices in many markets. The products of our therapeutic areas combine top quality active ingredients made in Europe with innovative and excellence of the manufacturing process. The concept that characterizes the philosophy of our company is orientation to results, dynamism, innovation and attention to the international market.
GermanyStand No: 5G30
Flavine has been working with advanced API manufacturers since 1975. Our offices are in the United States, Germany, Spain, France, China and India. We offer Active Pharmaceutical Ingredients, Fine Chemicals, Intermediates for API production and Pharmaceutical Finished Dosage Forms combined with Regulatory Affairs to support the marketing and sales in countries where USDMF, CEP and GMP certification is required.
ChinaStand No: 12A33
GeneScience Pharmaceuticals Co Ltd (GenSci) is one of the largest, most profitable and rapidly-growing biopharmaceutical companies in China, with 7 products on the market and over 10 products in the pipeline. GenSci's business is focused on developing, manufacturing and marketing biologics as well as innovative biogenerics. GenSci was awarded the first "Medical Center for Quality Controls of Genetic Engineering Pharmaceuticals" by Chinese Quality Association of Pharmaceuticals (CQAP) in 2007, and the first state genetic engineering "Enterprise's New Drug incubation base" & the state New Drug R&D Major Project of "Eleventh Five-Year Plan" in 2009. GenSci has achieved sustainable successes with rapid growth rates in the past twenty years. One of GenSci's important products, GenLei Jintropin (rhGH, Somatropin for Injection) has been the leading brand of rhGH in China with a dominant market share since launched in 1998.
LatviaStand No: 12F31
Grindeks is a vertically integrated pharmaceutical company from Latvia specializing in cardiovascular, CNS and anti-cancer products. Our portfolio of FDFs includes original products and generics. Currently Grindeks produces 24 APIs. Products are exported to 60 markets: of which EU, Japan, Russia and the USA are the main markets.
BrazilStand No: 9B20
Founded in 2001, Hypermarcas has consolidated its position as a leading pharmaceutical company in Brazil. The Company competes in all relevant segments of the sector, with leadership positioning in several product categories. The Company ranks #1 in OTC drugs, with leadership in segments such as flu symptoms, pain relief, and antacids, among others. Its brands are traditional, and have been established in the market for many years. In some cases, they are category icons, such as Benegrip, Engov, Epocler, Estomazil, Atroveran and Tamarine. In addition, the Company ranks #2 in the branded and unbranded generics, with the Neo Química franchise, which has more than 140 brands and 240 presentations of branded generics, and also 120 molecules and 190 presentations of generics. This segment, which has higher popular appeal, has allowed lower income classes to have access to medication in Brazil. Even so, it exhibits lower penetration levels compared to more...
JapanStand No: 7A61
Koa Shoji Co Ltd has been leading generic pharmaceuticals business in Japan as an importer of active pharmaceutical ingredients and intermediates. We have been devoting ourselves to pursue strict quality standard to satisfy our Japanese customers. For foreign API suppliers, we support them as a DMF in-country caretaker and assist their accreditation in Japan. We also update the information about Japanese API market with our own research.
GreeceStand No: 9A60
LABOCHEM SA has been established in 1990 as an agency and distribution company of APIs and excipients for the pharmaceutical, cosmetic and chemical industry, with headquarters in Athens, Greece. Our business activities have expanded all over the world in EU and CIS countries. Labochem develops generic products/dossiers available for exports and license out. We are also agents of machinery (processing and packaging) for the pharma, chemical, cosmetic, personal care and food industries.
IndiaStand No: 14.1F70
5th ranked Indian Pharmaceutical Company, having own R&D, BE Centre, API, Finished Dosage manufacturing sites, approved by USFDA,MHRA etc. Have CVS/CNS/Anti-Diabetic/Anti-HIV/AntiTB/Anti Asthmatic/Anti Malarial products with presence across 110 countries and subsidiaries in USA, UK, Spain, South Africa, Ukraine and Kazak. We offer: MA of EU,Out-licensing US/EUCTD with FDF/API Supply.
IndiaStand No: 7C60
Morepen Laboratories Limited is a 33 year old company manufacturing APIs (Loratadine, Desloratadine, Atorvastatin, Montelukast, Rosuvastatin, Fexofenadine, Olmesartan, Sitagliptin Linagliptin, Saxagliptin, Dapagliflozin, Canagliflozin etc.) at its world class manufacturing facilities, approved by USFDA, European & other regulatory authorities. Morepen adheres to latest cGMP standards, has DMF/CoS/Tech.Packs, exports to more than 60 countries.
ItalyStand No: 8H20
Newchem is an Italian company, established in 1998. Newchem, with Manufacturing facilities in Verona and San Martino Siccomario (Pavia) and Headquarter in Milano, manufactures a wide range of active pharmaceutical ingredients (API), in particular Steroids, Hormones and Prostaglandins, according to the strictest quality specifications. Newchem is active in the worldwide markets with its own know-how, and is intended to be an efficient, reliable and competitive supplier.
IndiaStand No: 7A90
Nutra is a pioneer manufacturer of unique niche APIs and have 3 COS Approval, 1 MHRA Approval and 2 Korean FDA Approvals. We are also simultaneously working on USFDA, ANVISA and Chinese SFDA for our key product Olmesartan Medoxomil. We are leaders in Warfarin Sodium, Tetracaine HCL and Olmesartan along with upcoming gliptin molecules. We have WHO GMP and ISO 9001:2008 certification and focus on stringent quality standards and continously upgrade our manufacturing technology to upkeep the competitive industry. We have crossed a revenue of USD 15Mn and have over 160 Employees and are aiming to be Leading Niche Manufacturer.
Hong Kong S.A.R., ChinaStand No: 8A31
Pen Tsao Chemical Industry Ltd produce in its Shanghai plant a range of API's and advanced pharma intermediates for domestic and International markets. The highly flexible multi-purpose production facilities focusing on development and production of Niche API's. The plant, under German management, is fully cGMP certified by National and International authorities. We are leader in MDR and XDR Tuberculosis WHO prequalified APIs.
GermanyStand No: 14.0C10
Pharma-Zentrale GmbH, located in Germany, is a GMP-certified pharmaceutical manufacturer with Manufacturers Authorization. Pharma-Zentrale GmbH is a specialist in probiotics (LBP - live biotherapeutic products and phytopharmaceutical products. Among other probiotic products like e.g. saccharomyces boulardii and lactobacillus acidophilus, we are producing the worldwide unique probiotic Mutaflor® with the API: E. Coli Nissle 1917. We are offering full service for production and packaging of liquids, capsules and tablets. Licensing and distribution is also available.
SpainStand No: 14.0J70
Founded in 1929, Reig Jofre is #5 Spanish pharmaceutical company by turnover that trades on the Spanish stock exchange under the ticker RJF. It is devoted to the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements, as well as on specialized contract development and manufacturing. The company directs its activity in two business units: • technological specialization area (49.7% of total sales) in the development and manufacture of antibiotics derived from penicillin and sterile injectable products, which made possible to grow internationally and distribute or license Reig Jofre products in more than 65 countries on five continents. • therapeutic areas and health care (50.3% of sales) focused on the research, development, manufacture and marketing of our own developments in dermatology and gynecology, mainly, and in the development of OTCs products in the field of ENT and topical disinfectants. This area also includes the line of nutritional supplements,...
FranceStand No: 6B61
Sanofi, a global life sciences company Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients' daily life, wherever they live and enable them to enjoy a healthier life.
GermanyStand No: 10A30
German based SRL Pharma (former BK Giulini GmbH) is a leading manufacturer of antacid compounds offering the widest range of products available from one supplier. SRL Pharma GmbH's manufacturing facilities operate to the highest standards under a total Quality concept which is an integral part of the company's philosophy. Our product portfolio covers a broad variety of Aluminium and Magnesium Hydroxides, Magaldrate, Hydrotalcite, Amalgate, Dihydroxy Aluminium Sodium Carbonate (DASC), Aluminium Phospate and Sucralfate as powders and suspensions. Customer-tailored products are available on request. Our antacid production facility is a GMP, FDA and ISO 9001, ISO 14001, BH OHSAS 18001 certified plant and is licensed to manufacture bulk antacid formulations to §13 of the German Drug Law.
SwitzerlandStand No: 6A11
STRAGEN is a global Health Care Company based in Geneva, Switzerland, focused on the development of niche generic pharmaceuticals, consumer health products, and drug development programmes. STRAGEN continues to grow by developing new products and expanding its international presence through a network of partners, exclusive distributors, and new affiliate offices.
United StatesStand No: 7H60SSP
Established in 2002, Tecoland represents selected cGMP manufacturers with proven capabilities in organic synthesis, fermentation production as well as process and method development. Tecoland provides high quality APIs to the pharmaceutical industry, with reliable technical and regulatory support such as USDMF, CEP, EDMF that are critical to the speedy approval of our customers' regulatory filings.
GreeceStand No: 1D50
Vioser S.A. is a dynamic and constantly expanding Greek pharmaceutical industry, established in 1984 in Trikala, Greece.Working strictly under the GMP regulations we can assure high quality, safety and reliability for our products and services. Our portfolio includes pharmaceutical I.V. solutions, generic antibiotics and CE marked irrigation solutions, bottled in polyethylene containers, produced with the Blow/Fill/Seal Technology®.
ChinaStand No: 6G18
Zhejiang Ausun Pharmaceutical Co Ltd, established in 2009 and covering an area of 70,000 square meters, is located in Zhejiang Chemical Materials Base, Linhai Zone. Ausun Pharma specializes in the development and manufacturing of formulations, APIs, pharmaceutical intermediates and fine chemicals,and plans to develop special varieties of medical products with high added-value, low energy consumption, low pollution and own intellectual property rights according to the market need. Honesty & win-win is our basic principle. Ausun Pharm. is your reliable Strategic Partner!
ChinaStand No: 7B20
Zhejiang Hisun Pharmaceutical Co., Ltd. located in Taizhou, Zhejiang Province, a coastal city in southeastern China, was founded in 1956. In year 2000, Hisun was listed as a public company in Shanghai A share Stock Exchange. Today, Hisun is one of the biggest manufacturing bases of antibiotic oncology products, and has become one of leading pharmaceutical manufacturers in China.